Advocacy intelligence hub — real-time data for patient organizations
Hospital Clinic of Barcelona — NA
Assiut University
Bristol-Myers Squibb
AQVESME: FDA approved
treatment of anemia in adults with alpha- or beta-thalassemia
University Research Institute for the Study of Genetic & Malignant Disorders in Childhood
Assiut University
Centre Hospitalier Metropole Savoie — NA
Tanta University — PHASE3
Hu Peng — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Reblozyl
Bristol Myers Squibb
Patient Assistance Programs1
AQVESME
Agios Pharmaceuticals, Inc.
AQVESME
(MITAPIVAT)Orphan drugAgios Pharmaceuticals, Inc.
Reblozyl
(LUSPATERCEPT)Orphan drugstandardCelgene Corporation
Chao Liu, PHD
Shenzhen Hemogen
Jun Shi, PhD
Regenerative Medicine Center and Red Blood Cell Disorders Center
📍 Tianjin, Tianjin Municipality
Farid Boulad, MD, MD
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
YALIANG LI
CorrectSequence Therapeutics (Shanghai) Co., Ltd
Bristol Myers Squibb
Bristol-Myers Squibb
Swee Lay Thein, M.D., MD
National Heart, Lung, and Blood Institute (NHLBI)
📍 BETHESDA, MD